Transcode Therapeutics Inc (RNAZ)

Transcode Therapeutics Inc (RNAZ) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $30.1M; returns 1 day +3.2%, 1 week +4.1%, 1 year -86.5%.

TransCode Therapeutics, Inc. (RNAZ) is a clinical-stage biotechnology company developing RNA-based therapeutics using its proprietary delivery platform for iron oxide nanoparticles conjugated to therapeutic RNA molecules (TTs).

Groups RNAZ belongs to

• Clinical Stage Biotech
• Biotechnology
• Oncology
• Healthcare
• Cancer Therapeutics
• R&D
• Pancreatic Cancer
• Clinical Stage

RNAZ financial model: income statement, cash flow and balance sheet